Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275
Discontinued
Reference number: GID-TA10375
Following on from information provided to NICE by the company in May 2020 the appraisal of Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin [ID1275] was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.